platform (IMAGE)
Caption
HKUMed, in collaboration with the US National Cancer Institute, has successfully developed an innovative big data platform, the CIDE, which is currently available for public access for identifying new immunotherapy regulators (https://cide.ccr.cancer.gov/).
Credit
The University of Hong Kong
Usage Restrictions
N/A
License
Original content